From Wikipedia, the free encyclopedia Pramlintide (trade name Symlin ) is an injectable amylin analogue drug for diabetes (both type 1 and 2), developed by Amylin Pharmaceuticals (now a wholly owned subsidiary of AstraZeneca)
Hypertension 2010;55(2):e13
Studies have shown that the medications dont just help treat diabetes and obesity, they also reduce the risk of heart disease, the leading cause of death in the U.S., she said
If you do drink, do so with food, slowly, and in moderation and never on an empty stomach
2,16 Medical ovulation induction prior to intrauterine insemination increases the likelihood of pregnancy when the cause of infertility is unknown or due to female factors
Front Pharmacol 11:601572 Shao C, Liu Y, Chen Z et al (2022) 3D two-photon brain imaging reveals dihydroartemisinin exerts antiepileptic effects by modulating iron homeostasis [J]